News and resources | Resources
Video 28 May 2020

Global Biopharma CEO/Top Executives COVID-19 Media Briefing – 28 May 2020 (Video)

By IFPMA
Share
Topics
COVID-19Vaccines

About IFPMA

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.

Learn more

Media Contact

Elliot Dunster

Related news and resources

Statement 9 Jun 2023

First-of-its-kind event brings together 10 companies that partnered to deliver vaccines and treatments in response to COVID-19

On 7 June 2023, IFPMA hosted a unique opportunity to hear from 10 companies, about the different partnership models that supported the industry’s response to COVID-19.  This open event included discussion on the challenges of scaling up manufacturing to meet global demand for vaccines and treatments, with representatives from MSD – Dr Reddy’s Laboratories; Gilead...

Read more
Statement 5 Jun 2023

G20 side event on Global Vaccine Research Collaborative

On 3 June, IFPMA delivered a statement at the PATH and CEPI side event on the “Global Vaccine Research Collaborative” at the G20 3rd Health Working Group Meeting in Hyderabad.

Read more
Statement 5 May 2023

Comment on WHO announcement that COVID-19 no longer a Public Health Emergency of International Concern

IFPMA comment on WHO announcement that COVID-19 no longer constitutes a PHEIC.

Read more
Top